tried sequence for 24 weeks. here is what happened.
Something I noticed reading old threads that I have not seen said out loud. The advice on rodent data in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers…
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
Stalled for 17 weeks, changed nothing, and it started moving again on week 26.
That is net peptide content, not purity. Different number, different meaning.
research use only, no human protocols, no injection instructions
The fatigue was genuinely awful for three weeks and then simply stopped. I know that is not useful information, but it is what happened.
the sequence variation is the real issue